Attached files
| file | filename |
|---|---|
| EX-99.7 - Sonnet BioTherapeutics Holdings, Inc. | ex99-7.htm |
| EX-99.6 - Sonnet BioTherapeutics Holdings, Inc. | ex99-6.htm |
| EX-99.5 - Sonnet BioTherapeutics Holdings, Inc. | ex99-5.htm |
| EX-99.4 - Sonnet BioTherapeutics Holdings, Inc. | ex99-4.htm |
| EX-99.3 - Sonnet BioTherapeutics Holdings, Inc. | ex99-3.htm |
| EX-99.2 - Sonnet BioTherapeutics Holdings, Inc. | ex99-2.htm |
| EX-99.1 - Sonnet BioTherapeutics Holdings, Inc. | ex99-1.htm |
| EX-23.1 - Sonnet BioTherapeutics Holdings, Inc. | ex23-1.htm |
| EX-4.12 - Sonnet BioTherapeutics Holdings, Inc. | ex4-12.htm |
| EX-4.11 - Sonnet BioTherapeutics Holdings, Inc. | ex4-11.htm |
| EX-3.8 - Sonnet BioTherapeutics Holdings, Inc. | ex3-8.htm |
| S-1/A - Sonnet BioTherapeutics Holdings, Inc. | forms-1a.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the reference of our firm under the caption “Experts” in this Amendment No. 1 to Registration Statement on Form S-1 of Chanticleer Holdings, Inc. (the “Company”), and to the incorporation by reference in this Registration Statement of our report, dated March 30, 2016, appearing in the Annual Report on Form 10-K of Chanticleer Holdings, Inc. as of and for the year ended December 31, 2015, filed March 31, 2016 with the U.S. Securities and Exchange Commission.
| /s/ Cherry Bekaert LLP | |
| Charlotte, North Carolina | |
| November 17 , 2016 |